110 related articles for article (PubMed ID: 15110627)
1. Experimental limb transplantation, part I: identification of an effective tapered triple combination immunosuppressive regime.
Ayrout C; Lanzetta M; Chunasuwankul R; Gal A; Owen ER
Transplant Proc; 2004 Apr; 36(3):669-74. PubMed ID: 15110627
[TBL] [Abstract][Full Text] [Related]
2. Experimental limb transplantation, part II: excellent return of function and indefinite survival after withdrawal of immunosuppression.
Lanzetta M; Ayrout C; Gal A; Dereli Z; Wright B; Lauer C; Owen ER
Transplant Proc; 2004 Apr; 36(3):675-9. PubMed ID: 15110628
[TBL] [Abstract][Full Text] [Related]
3. Donor leukocytes combine with immunosuppressive drug therapy to prolong limb allograft survival.
Kanatani T; Lanzetta M; Owen E; Matsumoto T; Fujioka H; Kurosaka M; McCaughan GW; Bishop GA
Transplant Proc; 2005 Jun; 37(5):2382-4. PubMed ID: 15964421
[TBL] [Abstract][Full Text] [Related]
4. Donor leukocytes combined with delayed immunosupressive drug therapy prolong limb allograft survival.
Matsumoto T; Kanatani T; Lanzetta M; Fujioka H; Kurosaka M; McCaughan GW; Bishop GA
Transplant Proc; 2005 Dec; 37(10):4630-3. PubMed ID: 16387186
[TBL] [Abstract][Full Text] [Related]
5. Experimental limb transplantation, part III: induction of tolerance in the rigorous strain combination of Brown Norway donor to Lewis recipient.
Kanatani T; Wright B; Lanzetta M; Molitor M; McCaughan GW; Bishop GA
Transplant Proc; 2004 Dec; 36(10):3276-82. PubMed ID: 15686745
[TBL] [Abstract][Full Text] [Related]
6. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
[TBL] [Abstract][Full Text] [Related]
7. [Limb allograft in rats: studies on optimal maintenance dose of FK506 and development of graft-versus-host-disease (GVHD)].
Weigao C
Fukuoka Igaku Zasshi; 1996 Sep; 87(9):197-205. PubMed ID: 8913057
[TBL] [Abstract][Full Text] [Related]
8. Transplantation of newborn esophagus: an experimental study.
Yamataka A; Wang K; Kobayashi H; Unemoto K; Miyahara K; Sueyoshi N; Miyano T
J Pediatr Surg; 2001 Aug; 36(8):1255-7. PubMed ID: 11479870
[TBL] [Abstract][Full Text] [Related]
9. Is the malononitrilamide FK778 better for the prevention of acute or chronic rejection?
Deuse T; Schrepfer S; Pelletier MP; Fischbein MP; Robbins RC; Reichenspurner H
Transplant Proc; 2007 Mar; 39(2):569-72. PubMed ID: 17362784
[TBL] [Abstract][Full Text] [Related]
10. [Individual immunosuppressive regime in heart transplantation with high risk].
Wu XJ; Chen LW; Chen DZ; Huang XS; Cao H
Zhonghua Wai Ke Za Zhi; 2008 Jun; 46(11):820-2. PubMed ID: 19035214
[TBL] [Abstract][Full Text] [Related]
11. Sentinel skin allograft-a reliable marker for monitoring of composite tissue transplant rejection.
Zamfirescu DG; Owen E; Lascar I; Molitor M; Zegrea I; Popescu M; Bishop GA; Lauer CA; Simionescu M; Climov M; Lanzetta M
Transplant Proc; 2009 Mar; 41(2):503-8. PubMed ID: 19328913
[TBL] [Abstract][Full Text] [Related]
12. Prolonged amelioration of acute lung allograft rejection by overexpression of human interleukin-10 under control of a long acting ubiquitin C promoter in rats.
Stammberger U; Bilici M; Gugger M; Gazdhar A; Hamacher J; Hyde SC; Schmid RA
J Heart Lung Transplant; 2006 Dec; 25(12):1474-9. PubMed ID: 17178344
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effect of low dose cyclosporine A and human interleukin 10 overexpression on acute rejection in rat lung allotransplantation.
Pierog J; Gazdhar A; Stammberger U; Gugger M; Hyde S; Mathiesen I; Grodzki T; Schmid RA
Eur J Cardiothorac Surg; 2005 Jun; 27(6):1030-5. PubMed ID: 15896613
[TBL] [Abstract][Full Text] [Related]
14. Long-term limb allograft survival using a short course of anti-CD45RB monoclonal antibody, LF 15-0195, and rapamycin in a mouse model.
Zhong T; Liu Y; Jiang J; Wang H; Temple CL; Sun H; Garcia B; Zhong R; Ross DC
Transplantation; 2007 Dec; 84(12):1636-43. PubMed ID: 18165776
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of inhaled tacrolimus in rat lung transplantation.
Ide N; Nagayasu T; Matsumoto K; Tagawa T; Tanaka K; Taguchi T; Sumida Y; Nakashima M
J Thorac Cardiovasc Surg; 2007 Feb; 133(2):548-53. PubMed ID: 17258598
[TBL] [Abstract][Full Text] [Related]
16. Combined treatment of glatiramer acetate and low doses of immunosuppressive drugs is effective in the prevention of graft rejection.
Aharoni R; Yussim A; Sela M; Arnon R
Int Immunopharmacol; 2005 Jan; 5(1):23-32. PubMed ID: 15589456
[TBL] [Abstract][Full Text] [Related]
17. The effect of full dose composite tissue allotransplantation immunosuppression on allograft motor nerve regeneration in a rat sciatic nerve model.
Kim JP; Hundepool CA; Friedrich PF; Moran SL; Bishop AT; Shin AY
Microsurgery; 2018 Jan; 38(1):66-75. PubMed ID: 28792625
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of glucocorticoid-free immunosuppressive regimen in allogenic islet transplantation.
Du CY; Xu EK
Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):43-7. PubMed ID: 16481281
[TBL] [Abstract][Full Text] [Related]
19. [Control of the rejection process treated with cyclosporine and RS-61443, in allogeneic microsurgery transplantation of a limb, in rats].
Ferreira LM; Anthony JP; Borsanyi JP; Benhaim P; Mathes SJ; Laredo Filho J; Andrews JM
Rev Assoc Med Bras (1992); 1995; 41(1):11-9. PubMed ID: 7550407
[TBL] [Abstract][Full Text] [Related]
20. Prolonged limb allograft survival with short-term treatment with FK-506 in rats.
Arai K; Hotokebuchi T; Miyahara H; Arita C; Mohtai M; Sugioka Y; Kaibara N
Transplant Proc; 1989 Feb; 21(1 Pt 3):3191-3. PubMed ID: 2468256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
